Cartilage tissue engineering is an emerging technology for the regeneration of such tissues damaged by disease or trauma. Unlike other types of tissue, cartilage does not have a blood supply and, therefore, lacks regenerative capabilities. Hence, there is an urgent need to develop cartilage tissues in clinically translatable conditions for regeneration. This fi eld of research involves the choice of the appropriate cells and biomaterials, devising signaling factors to the defect site for regeneration. The objective of this chapter is to provide a comprehensive synopsis of different approaches and recent advancements that have been taking place in this area, with an emphasis on various biomimetic polysaccharide-based biomaterials with integrated cell sources (e.g., chondrocytes, fi broblasts, and stem cells). Stem cells undergo chondrogenesis and deposit neocartilage in a variety of biomaterialbased scaffolds. However, there is still a limitation in recapitulating the properties of native tissues. Thus, the design of biomaterials that support the distribution of formed tissue is crucial for the optimization of cartilage formation. The state-ofthe art of advances in biomaterials and knowledge of their interaction with cells are also evaluated in this chapter. Additionally, the importance of signaling factors on cellular behavior that promote the production of cartilage tissue, that, in turn, mimics native tissue properties, accelerates restoration of tissue function and is clinically translatable, has been addressed here. Finally, the challenges, limitation and future prospect of cartilage regeneration are discussed.